Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| COGNEX CORPCGNX · Entity 3527 | Director · CEO & President | August 11, 2026 | August 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
COGNEX CORP
Report date August 11, 2026 · Filed August 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,884 |
Ending reported balance
After 2026-08-11 transaction · row 9
9 source rows · reconciled sequenceRow 1 · 2026-08-11 · Exercise / conversion · Acquired 1,600 · Balance 20,846 F1: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Row 2 · 2026-08-11 · Sale · Disposed 1,600 · Balance 19,246 F1: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Row 3 · 2026-08-11 · Exercise / conversion · Acquired 4,000 · Balance 23,246 F1: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Row 4 · 2026-08-11 · Sale · Disposed 4,000 · Balance 19,246 F1: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Row 5 · 2026-08-11 · Exercise / conversion · Acquired 4,000 · Balance 23,246 F1: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Row 6 · 2026-08-11 · Sale · Disposed 4,000 · Balance 19,246 F1: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Row 7 · 2026-08-11 · Exercise / conversion · Acquired 7,000 · Balance 26,246 F1: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Row 8 · 2026-08-11 · Sale · Disposed 7,000 · Balance 19,246 F1: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Row 9 · 2026-08-11 · Sale · Disposed 8,362 · Balance 10,884 F2: These shares were disposed of in an open market sale pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $40.71 · Expires 2028-11-19 | Direct | 0 |
Reported balance
After 2026-08-11 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2026-08-11 · Exercise / conversion · Disposed 4,000 · Balance 0 F1: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F3: The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (November 19, 2018). |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $42.84 · Expires 2028-10-31 | Direct | 0 |
Reported balance
After 2026-08-11 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2026-08-11 · Exercise / conversion · Disposed 7,000 · Balance 0 F1: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F4: The options vest approximately 50% on the third anniversary of the grant date (October 31, 2018) and 50% on the fourth anniversary of the grant date. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $51.49 · Expires 2029-02-19 | Direct | 0 |
Reported balance
After 2026-08-11 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2026-08-11 · Exercise / conversion · Disposed 4,000 · Balance 0 F1: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F5: The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 19, 2019). |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $56.44 · Expires 2028-02-20 | Direct | 0 |
Reported balance
After 2026-08-11 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2026-08-11 · Exercise / conversion · Disposed 1,600 · Balance 0 F1: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F6: The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 20, 2018). |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $27.99 · Expires 2035-05-05 | Direct | 279,070 |
Reported balance
Holding disclosure · report date 2026-08-11 · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · Balance 279,070 |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $32.78 · Expires 2035-02-21 | Direct | 76,924 |
Reported balance
Holding disclosure · report date 2026-08-11 · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · Balance 76,924 |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $33.04 · Expires 2035-02-18 | Direct | 68,823 |
Reported balance
Holding disclosure · report date 2026-08-11 · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · Balance 68,823 |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $39.44 · Expires 2034-02-20 | Direct | 58,260 |
Reported balance
Holding disclosure · report date 2026-08-11 · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · Balance 58,260 |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $47.21 · Expires 2033-02-21 | Direct | 37,832 |
Reported balance
Holding disclosure · report date 2026-08-11 · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · Balance 37,832 |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $47.95 · Expires 2032-08-04 | Direct | 35,639 |
Reported balance
Holding disclosure · report date 2026-08-11 · row 19
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 19 · Balance 35,639 |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $50.01 · Expires 2033-08-07 | Direct | 47,962 |
Reported balance
Holding disclosure · report date 2026-08-11 · row 20
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 20 · Balance 47,962 |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $51.97 · Expires 2029-10-30 | Direct | 9,000 |
Reported balance
Holding disclosure · report date 2026-08-11 · row 21
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 21 · Balance 9,000 |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $57.09 · Expires 2036-02-17 | Direct | 58,744 |
Reported balance
Holding disclosure · report date 2026-08-11 · row 22
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 22 · Balance 58,744 |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $86.38 · Expires 2031-08-09 | Direct | 8,426 |
Reported balance
Holding disclosure · report date 2026-08-11 · row 23
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 23 · Balance 8,426 |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2027-02-20 | Direct | 5,071 |
Reported balance
Holding disclosure · report date 2026-08-11 · row 24
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 24 · Balance 5,071 |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2028-02-18 | Direct | 20,339 |
Reported balance
Holding disclosure · report date 2026-08-11 · row 25
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 25 · Balance 20,339 |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2029-02-17 | Direct | 56,928 |
Reported balance
Holding disclosure · report date 2026-08-11 · row 26
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 26 · Balance 56,928 |
Filing footnotes · ownership attribution and instrument terms
F1: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
F2: These shares were disposed of in an open market sale pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
F3: The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (November 19, 2018).
F4: The options vest approximately 50% on the third anniversary of the grant date (October 31, 2018) and 50% on the fourth anniversary of the grant date.
F5: The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 19, 2019).
F6: The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 20, 2018).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 11, 2026 Filed Aug 12, 2026 20:00 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,600 | $0.00 Strike: $56.44 | $0.00 |
DisclosureSEC source: 0002054688-26-000008 · edgardoc.xml · derivative · entry 13 Moschner Matthew · CIK 0002054688 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,600 shares Expires 2028-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F6 · derivative.exercise_date: The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 20, 2018). Read SEC document |
| August 11, 2026 Filed Aug 12, 2026 20:00 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $51.49 | $0.00 |
DisclosureSEC source: 0002054688-26-000008 · edgardoc.xml · derivative · entry 12 Moschner Matthew · CIK 0002054688 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires 2029-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F5 · derivative.exercise_date: The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 19, 2019). Read SEC document |
| August 11, 2026 Filed Aug 12, 2026 20:00 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $42.84 | $0.00 |
DisclosureSEC source: 0002054688-26-000008 · edgardoc.xml · derivative · entry 11 Moschner Matthew · CIK 0002054688 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,000 shares Expires 2028-10-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F4 · derivative.exercise_date: The options vest approximately 50% on the third anniversary of the grant date (October 31, 2018) and 50% on the fourth anniversary of the grant date. Read SEC document |
| August 11, 2026 Filed Aug 12, 2026 20:00 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $40.71 | $0.00 |
DisclosureSEC source: 0002054688-26-000008 · edgardoc.xml · derivative · entry 10 Moschner Matthew · CIK 0002054688 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires 2028-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F3 · derivative.exercise_date: The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (November 19, 2018). Read SEC document |
| August 11, 2026 Filed Aug 12, 2026 20:00 UTC | COGNEX CORP CGNX · Entity 3527 | SaleCommon Stock | 8,362 | $63.62 | $531,998.80 |
DisclosureSEC source: 0002054688-26-000008 · edgardoc.xml · nonDerivative · entry 9 Moschner Matthew · CIK 0002054688 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,884 F2 · kind: These shares were disposed of in an open market sale pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| August 11, 2026 Filed Aug 12, 2026 20:00 UTC | COGNEX CORP CGNX · Entity 3527 | SaleCommon Stock | 7,000 | $63.61 | $445,271.40 |
DisclosureSEC source: 0002054688-26-000008 · edgardoc.xml · nonDerivative · entry 8 Moschner Matthew · CIK 0002054688 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,246 F1 · kind: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| August 11, 2026 Filed Aug 12, 2026 20:00 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 7,000 | $42.84 | $299,880.00 |
DisclosureSEC source: 0002054688-26-000008 · edgardoc.xml · nonDerivative · entry 7 Moschner Matthew · CIK 0002054688 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,246 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| August 11, 2026 Filed Aug 12, 2026 20:00 UTC | COGNEX CORP CGNX · Entity 3527 | SaleCommon Stock | 4,000 | $63.62 | $254,463.20 |
DisclosureSEC source: 0002054688-26-000008 · edgardoc.xml · nonDerivative · entry 6 Moschner Matthew · CIK 0002054688 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,246 F1 · kind: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| August 11, 2026 Filed Aug 12, 2026 20:00 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 4,000 | $40.71 | $162,840.00 |
DisclosureSEC source: 0002054688-26-000008 · edgardoc.xml · nonDerivative · entry 5 Moschner Matthew · CIK 0002054688 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,246 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| August 11, 2026 Filed Aug 12, 2026 20:00 UTC | COGNEX CORP CGNX · Entity 3527 | SaleCommon Stock | 4,000 | $65.36 | $261,440.00 |
DisclosureSEC source: 0002054688-26-000008 · edgardoc.xml · nonDerivative · entry 4 Moschner Matthew · CIK 0002054688 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,246 F1 · kind: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| August 11, 2026 Filed Aug 12, 2026 20:00 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 4,000 | $51.49 | $205,960.00 |
DisclosureSEC source: 0002054688-26-000008 · edgardoc.xml · nonDerivative · entry 3 Moschner Matthew · CIK 0002054688 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,246 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| August 11, 2026 Filed Aug 12, 2026 20:00 UTC | COGNEX CORP CGNX · Entity 3527 | SaleCommon Stock | 1,600 | $65.36 | $104,576.00 |
DisclosureSEC source: 0002054688-26-000008 · edgardoc.xml · nonDerivative · entry 2 Moschner Matthew · CIK 0002054688 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,246 F1 · kind: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| August 11, 2026 Filed Aug 12, 2026 20:00 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 1,600 | $56.44 | $90,304.00 |
DisclosureSEC source: 0002054688-26-000008 · edgardoc.xml · nonDerivative · entry 1 Moschner Matthew · CIK 0002054688 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,846 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| August 07, 2026 Filed Aug 11, 2026 20:18 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionRestricted Stock Unit · Derivative | 4,999 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002054688-26-000006 · edgardoc.xml · derivative · entry 3 Moschner Matthew · CIK 0002054688 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,999 shares Expires 2026-08-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (August 7, 2023), respectively. Read SEC document |
| August 07, 2026 Filed Aug 11, 2026 20:18 UTC | COGNEX CORP CGNX · Entity 3527 | Tax withholdingCommon Stock | 2,218 | $66.89 | $148,362.02 |
DisclosureSEC source: 0002054688-26-000006 · edgardoc.xml · nonDerivative · entry 2 Moschner Matthew · CIK 0002054688 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,246 F1 · kind: This disposition represents shares withheld to satisfy tax withholding obligations on the restricted stock units that vested on August 7, 2026 and are reported herein. Read SEC document |
| August 07, 2026 Filed Aug 11, 2026 20:18 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 4,999 | $0.00 | $0.00 |
DisclosureSEC source: 0002054688-26-000006 · edgardoc.xml · nonDerivative · entry 1 Moschner Matthew · CIK 0002054688 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,464 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2026 Filed Feb 24, 2026 21:31 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionRestricted Stock Unit · Derivative | 3,495 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002054688-26-000004 · edgardoc.xml · derivative · entry 5 Moschner Matthew · CIK 0002054688 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,495 shares Expires 2026-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. F4 · derivative.exercise_date: The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 21, 2023), respectively. Read SEC document |
| February 21, 2026 Filed Feb 24, 2026 21:31 UTC | COGNEX CORP CGNX · Entity 3527 | Tax withholdingCommon Stock | 1,026 | $56.03 | $57,486.78 |
DisclosureSEC source: 0002054688-26-000004 · edgardoc.xml · nonDerivative · entry 4 Moschner Matthew · CIK 0002054688 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,465 F2 · kind: This disposition represents shares withheld to satisfy tax withholding obligations on the restricted stock units that vested on February 21, 2026 and are reported herein. Read SEC document |
| February 21, 2026 Filed Feb 24, 2026 21:31 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 3,495 | $0.00 | $0.00 |
DisclosureSEC source: 0002054688-26-000004 · edgardoc.xml · nonDerivative · entry 3 Moschner Matthew · CIK 0002054688 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,491 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 21:31 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionRestricted Stock Unit · Derivative | 3,042 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002054688-26-000004 · edgardoc.xml · derivative · entry 6 Moschner Matthew · CIK 0002054688 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,071 Underlying: Common Stock · 3,042 shares Expires 2027-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. F5 · derivative.exercise_date: The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 20, 2024), respectively. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 21:31 UTC | COGNEX CORP CGNX · Entity 3527 | Tax withholdingCommon Stock | 893 | $56.03 | $50,034.79 |
DisclosureSEC source: 0002054688-26-000004 · edgardoc.xml · nonDerivative · entry 2 Moschner Matthew · CIK 0002054688 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,996 F1 · kind: This disposition represents shares withheld to satisfy tax withholding obligations on the restricted stock units that vested on February 20, 2026 and are reported herein. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 21:31 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 3,042 | $0.00 | $0.00 |
DisclosureSEC source: 0002054688-26-000004 · edgardoc.xml · nonDerivative · entry 1 Moschner Matthew · CIK 0002054688 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,889 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2026 Filed Feb 19, 2026 21:59 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionRestricted Stock Unit · Derivative | 5,085 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002054688-26-000002 · edgardoc.xml · derivative · entry 4 Moschner Matthew · CIK 0002054688 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,339 Underlying: Common Stock · 5,085 shares Expires 2028-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. F4 · derivative.exercise_date: The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 18, 2025), respectively. Read SEC document |
| February 18, 2026 Filed Feb 19, 2026 21:59 UTC | COGNEX CORP CGNX · Entity 3527 | Tax withholdingCommon Stock | 1,600 | $56.72 | $90,752.00 |
DisclosureSEC source: 0002054688-26-000002 · edgardoc.xml · nonDerivative · entry 2 Moschner Matthew · CIK 0002054688 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,847 F1 · kind: This disposition represents shares withheld to satisfy tax withholding obligations on the restricted stock units that vested on February 18, 2026 and are reported herein. Read SEC document |
| February 18, 2026 Filed Feb 19, 2026 21:59 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 5,085 | $0.00 | $0.00 |
DisclosureSEC source: 0002054688-26-000002 · edgardoc.xml · nonDerivative · entry 1 Moschner Matthew · CIK 0002054688 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,447 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:59 UTC | COGNEX CORP CGNX · Entity 3527 | GrantRestricted Stock Unit · Derivative | 56,928 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002054688-26-000002 · edgardoc.xml · derivative · entry 5 Moschner Matthew · CIK 0002054688 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,928 Underlying: Common Stock · 56,928 shares Expires 2029-02-17 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. F5 · derivative.exercise_date: The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 17, 2026), respectively. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:59 UTC | COGNEX CORP CGNX · Entity 3527 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 58,744 | $0.00 Strike: $57.09 | $0.00 |
DisclosureSEC source: 0002054688-26-000002 · edgardoc.xml · derivative · entry 3 Moschner Matthew · CIK 0002054688 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,744 Underlying: Common Stock · 58,744 shares Expires 2036-02-17 F2 · derivative.exercise_date: The options vest in five approximately equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 17, 2026). Read SEC document |
| August 07, 2025 Filed Aug 11, 2025 20:40 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionRestricted Stock Unit · Derivative | 3,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002054688-25-000014 · edgardoc.xml · derivative · entry 3 Moschner Matthew · CIK 0002054688 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,999 Underlying: Common Stock · 3,000 shares Expires 2026-08-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (August 7, 2023), respectively. Read SEC document |
| August 07, 2025 Filed Aug 11, 2025 20:40 UTC | COGNEX CORP CGNX · Entity 3527 | Tax withholdingCommon Stock | 881 | $41.36 | $36,438.16 |
DisclosureSEC source: 0002054688-25-000014 · edgardoc.xml · nonDerivative · entry 2 Moschner Matthew · CIK 0002054688 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,362 F1 · kind: This disposition represents shares withheld to satisfy tax withholding obligations on the restricted stock units that vested on August 7, 2025, and are reported herein. Read SEC document |
| August 07, 2025 Filed Aug 11, 2025 20:40 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0002054688-25-000014 · edgardoc.xml · nonDerivative · entry 1 Moschner Matthew · CIK 0002054688 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,243 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 04, 2025 Filed Aug 5, 2025 20:00 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionRestricted Stock Unit · Derivative | 3,441 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002054688-25-000012 · edgardoc.xml · derivative · entry 3 Moschner Matthew · CIK 0002054688 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,441 shares Expires 2025-08-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (August 4, 2022), respectively. Read SEC document |
| August 04, 2025 Filed Aug 5, 2025 20:00 UTC | COGNEX CORP CGNX · Entity 3527 | Tax withholdingCommon Stock | 1,010 | $41.43 | $41,844.30 |
DisclosureSEC source: 0002054688-25-000012 · edgardoc.xml · nonDerivative · entry 2 Moschner Matthew · CIK 0002054688 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,243 F1 · kind: This disposition represents shares withheld to satisfy tax withholding obligations on the restricted stock units that vested on August 4, 2025, and are reported herein. Read SEC document |
| August 04, 2025 Filed Aug 5, 2025 20:00 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 3,441 | $0.00 | $0.00 |
DisclosureSEC source: 0002054688-25-000012 · edgardoc.xml · nonDerivative · entry 1 Moschner Matthew · CIK 0002054688 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,253 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2025 Filed May 7, 2025 20:06 UTC | COGNEX CORP CGNX · Entity 3527 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 279,070 | $0.00 Strike: $27.99 | $0.00 |
DisclosureSEC source: 0002054688-25-000004 · edgardoc.xml · derivative · entry 2 Moschner Matthew · CIK 0002054688 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 279,070 Underlying: Common Stock · 279,070 shares Expires 2035-05-05 F1 · derivative.exercise_date: The options vest approximately 50% on the fourth anniversary of the grant date (May 5, 2025) and 50% on the fifth anniversary of the grant date. Read SEC document |
| February 22, 2025 Filed Feb 24, 2025 21:46 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionRestricted Stock Unit · Derivative | 1,552 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001829813-25-000016 · edgardoc.xml · derivative · entry 8 Moschner Matthew · CIK 0002054688 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,552 shares Expires 2025-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. F6 · derivative.exercise_date: The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 22, 2022), respectively. Read SEC document |
| February 22, 2025 Filed Feb 24, 2025 21:46 UTC | COGNEX CORP CGNX · Entity 3527 | Tax withholdingCommon Stock | 452 | $32.78 | $14,816.56 |
DisclosureSEC source: 0001829813-25-000016 · edgardoc.xml · nonDerivative · entry 6 Moschner Matthew · CIK 0002054688 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,812 F3 · kind: This disposition represents shares withheld to satisfy tax withholding obligations on the restricted stock units that vested on February 22, 2025 and are reported herein. Read SEC document |
| February 22, 2025 Filed Feb 24, 2025 21:46 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 1,552 | $0.00 | $0.00 |
DisclosureSEC source: 0001829813-25-000016 · edgardoc.xml · nonDerivative · entry 5 Moschner Matthew · CIK 0002054688 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,264 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2025 Filed Feb 24, 2025 21:46 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionRestricted Stock Unit · Derivative | 2,097 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001829813-25-000016 · edgardoc.xml · derivative · entry 9 Moschner Matthew · CIK 0002054688 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,495 Underlying: Common Stock · 2,097 shares Expires 2026-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. F7 · derivative.exercise_date: The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 21, 2023), respectively. Read SEC document |
| February 21, 2025 Filed Feb 24, 2025 21:46 UTC | COGNEX CORP CGNX · Entity 3527 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 76,924 | $0.00 Strike: $32.78 | $0.00 |
DisclosureSEC source: 0001829813-25-000016 · edgardoc.xml · derivative · entry 7 Moschner Matthew · CIK 0002054688 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,924 Underlying: Common Stock · 76,924 shares Expires 2035-02-21 F4 · derivative.exercise_date: The options vest approximately 50% on the fourth anniversary of the grant date (February 21, 2025) and 50% on the fifth anniversary of the grant date. Read SEC document |
| February 21, 2025 Filed Feb 24, 2025 21:46 UTC | COGNEX CORP CGNX · Entity 3527 | Tax withholdingCommon Stock | 710 | $32.78 | $23,273.80 |
DisclosureSEC source: 0001829813-25-000016 · edgardoc.xml · nonDerivative · entry 4 Moschner Matthew · CIK 0002054688 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,712 F2 · kind: This disposition represents shares withheld to satisfy tax withholding obligations on the restricted stock units that vested on February 21, 2025 and are reported herein. Read SEC document |
| February 21, 2025 Filed Feb 24, 2025 21:46 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 2,097 | $0.00 | $0.00 |
DisclosureSEC source: 0001829813-25-000016 · edgardoc.xml · nonDerivative · entry 3 Moschner Matthew · CIK 0002054688 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,422 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:46 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionRestricted Stock Unit · Derivative | 2,029 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001829813-25-000016 · edgardoc.xml · derivative · entry 10 Moschner Matthew · CIK 0002054688 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,113 Underlying: Common Stock · 2,029 shares Expires 2027-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. F8 · derivative.exercise_date: The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 20, 2024), respectively. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:46 UTC | COGNEX CORP CGNX · Entity 3527 | Tax withholdingCommon Stock | 704 | $33.40 | $23,513.60 |
DisclosureSEC source: 0001829813-25-000016 · edgardoc.xml · nonDerivative · entry 2 Moschner Matthew · CIK 0002054688 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,325 F1 · kind: This disposition represents shares withheld to satisfy tax withholding obligations on the restricted stock units that vested on February 20, 2025 and are reported herein. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:46 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 2,029 | $0.00 | $0.00 |
DisclosureSEC source: 0001829813-25-000016 · edgardoc.xml · nonDerivative · entry 1 Moschner Matthew · CIK 0002054688 · President and COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,029 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:23 UTC | COGNEX CORP CGNX · Entity 3527 | GrantRestricted Stock Unit · Derivative | 25,424 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001721515-25-000014 · edgardoc.xml · derivative · entry 17 Moschner Matthew · CIK 0002054688 · Senior Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,424 Underlying: Common Stock · 25,424 shares Expires 2028-02-18 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 18, 2025), respectively. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:23 UTC | COGNEX CORP CGNX · Entity 3527 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 68,823 | $0.00 Strike: $33.04 | $0.00 |
DisclosureSEC source: 0001721515-25-000014 · edgardoc.xml · derivative · entry 1 Moschner Matthew · CIK 0002054688 · Senior Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,823 Underlying: Common Stock · 68,823 shares Expires 2035-02-18 F1 · derivative.exercise_date: The options vest in five approximately equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 18, 2025). Read SEC document |
| February 20, 2024 Filed Feb 20, 2025 22:23 UTC | COGNEX CORP CGNX · Entity 3527 | GrantRestricted Stock Unit · Derivative | 10,142 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001721515-25-000014 · edgardoc.xml · derivative · entry 16 Moschner Matthew · CIK 0002054688 · Senior Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,142 Underlying: Common Stock · 10,142 shares Expires 2027-02-20 Read SEC document |
| February 20, 2024 Filed Feb 20, 2025 22:23 UTC | COGNEX CORP CGNX · Entity 3527 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 58,260 | $0.00 Strike: $39.44 | $0.00 |
DisclosureSEC source: 0001721515-25-000014 · edgardoc.xml · derivative · entry 2 Moschner Matthew · CIK 0002054688 · Senior Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,260 Underlying: Common Stock · 58,260 shares Expires 2034-02-20 Read SEC document |
| August 07, 2023 Filed Feb 20, 2025 22:23 UTC | COGNEX CORP CGNX · Entity 3527 | GrantRestricted Stock Unit · Derivative | 7,999 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001721515-25-000014 · edgardoc.xml · derivative · entry 15 Moschner Matthew · CIK 0002054688 · Senior Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,999 Underlying: Common Stock · 7,999 shares Expires 2026-08-07 Read SEC document |
| August 07, 2023 Filed Feb 20, 2025 22:23 UTC | COGNEX CORP CGNX · Entity 3527 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 47,962 | $0.00 Strike: $50.01 | $0.00 |
DisclosureSEC source: 0001721515-25-000014 · edgardoc.xml · derivative · entry 7 Moschner Matthew · CIK 0002054688 · Senior Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,962 Underlying: Common Stock · 47,962 shares Expires 2033-08-07 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.